{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T19:19:34Z","timestamp":1788808774291,"version":"build-2803163510"},"reference-count":25,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2022,11,3]],"date-time":"2022-11-03T00:00:00Z","timestamp":1667433600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01 AI127365"],"award-info":[{"award-number":["R01 AI127365"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01 AI121054"],"award-info":[{"award-number":["R01 AI121054"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01 AI33144"],"award-info":[{"award-number":["R01 AI33144"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccines"],"abstract":"<jats:p>As an extremely contagious pathogen, a high rate of vaccine coverage and the durability of vaccine-induced immunity are key factors to control and eliminate measles. Herein, we assessed the seroprevalence of antibodies specific to measles in a cohort of 1393 adults (20\u201344 years old). ELISA results showed a nontrivial proportion of 37.6% study subjects being negative for measles immunoglobulin G (IgG). We also found significant influences of sex and age of the study cohort on the IgG level. Our findings suggest that even within a highly vaccinated population, a subset of individuals may still have sub-optimal immunity against measles and potentially be susceptible during any future measles outbreaks.<\/jats:p>","DOI":"10.3390\/vaccines10111859","type":"journal-article","created":{"date-parts":[[2022,11,4]],"date-time":"2022-11-04T04:00:51Z","timestamp":1667534451000},"page":"1859","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Seroprevalence of Measles Antibodies in a Highly MMR-Vaccinated Population"],"prefix":"10.3390","volume":"10","author":[{"given":"Huy Quang","family":"Quach","sequence":"first","affiliation":[{"name":"Mayo Clinic Vaccine Research Group, Division of General of Internal Medicine, Mayo Clinic, Rochester, MN 55905, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inna G.","family":"Ovsyannikova","sequence":"additional","affiliation":[{"name":"Mayo Clinic Vaccine Research Group, Division of General of Internal Medicine, Mayo Clinic, Rochester, MN 55905, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane E.","family":"Grill","sequence":"additional","affiliation":[{"name":"Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN 55905, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathaniel D.","family":"Warner","sequence":"additional","affiliation":[{"name":"Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN 55905, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory A.","family":"Poland","sequence":"additional","affiliation":[{"name":"Mayo Clinic Vaccine Research Group, Division of General of Internal Medicine, Mayo Clinic, Rochester, MN 55905, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6164-4967","authenticated-orcid":false,"given":"Richard B.","family":"Kennedy","sequence":"additional","affiliation":[{"name":"Mayo Clinic Vaccine Research Group, Division of General of Internal Medicine, Mayo Clinic, Rochester, MN 55905, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,11,3]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1542\/peds.76.4.524","article-title":"Health impact of measles vaccination in the United States","volume":"76","author":"Bloch","year":"1985","journal-title":"Pediatrics"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1086\/377696","article-title":"Summary and conclusions: Measles elimination meeting, 16\u201317 March 2000","volume":"189","author":"Katz","year":"2004","journal-title":"J. Infect. Dis."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"893","DOI":"10.15585\/mmwr.mm6840e2","article-title":"National Update on Measles Cases and Outbreaks\u2014United States, January 1\u2013October 1, 2019","volume":"68","author":"Patel","year":"2019","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.15585\/mmwr.mm7045a1","article-title":"Progress Toward Regional Measles Elimination\u2014Worldwide, 2000\u20132020","volume":"70","author":"Dixon","year":"2021","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1038\/s41591-021-01237-5","article-title":"A dangerous measles future looms beyond the COVID-19 pandemic","volume":"27","author":"Durrheim","year":"2021","journal-title":"Nat. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"e67023","DOI":"10.7554\/eLife.67023","article-title":"Impact of COVID-19-related disruptions to measles, meningococcal A, and yellow fever vaccination in 10 countries","volume":"10","author":"Gaythorpe","year":"2021","journal-title":"Elife"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"S123","DOI":"10.1086\/380308","article-title":"Persistence of vaccine-induced antibody to measles 26\u201333 years after vaccination","volume":"189","author":"Dine","year":"2004","journal-title":"J. Infect. Dis."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1017\/S0950268800057824","article-title":"Measles vaccine: A 27-year follow-up","volume":"112","author":"Ramsay","year":"1994","journal-title":"Epidemiol. Infect."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/S1473-3099(20)30442-4","article-title":"Immunogenicity and persistence of trivalent measles, mumps, and rubella vaccines: A systematic review and meta-analysis","volume":"21","author":"Schenk","year":"2021","journal-title":"Lancet Infect. Dis."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1093\/infdis\/jiac039","article-title":"In Elimination Settings, Measles Antibodies Wane Following Vaccination but Not Following Infection\u2014A Systematic Review and Meta-Analysis","volume":"226","author":"Bolotin","year":"2022","journal-title":"J. Infect. Dis."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"3876","DOI":"10.1016\/j.vaccine.2019.05.049","article-title":"Seroprevalence and durability of rubella virus antibodies in a highly immunized population","volume":"37","author":"Crooke","year":"2019","journal-title":"Vaccine"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1093\/infdis\/162.5.1036","article-title":"Measles antibody: Reevaluation of protective titers","volume":"162","author":"Chen","year":"1990","journal-title":"J. Infect. Dis."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1097\/00006454-199401000-00008","article-title":"Measles vaccine failures: Lack of sustained measles-specific immunoglobulin G responses in revaccinated adolescents and young adults","volume":"13","author":"Cohn","year":"1994","journal-title":"Pediatr. Infect. Dis. J."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1093\/cid\/ciu105","article-title":"Outbreak of measles among persons with prior evidence of immunity, New York City, 2011","volume":"58","author":"Rosen","year":"2014","journal-title":"Clin. Infect. Dis."},{"key":"ref_15","first-page":"1","article-title":"Prevention of measles, rubella, congenital rubella syndrome, and mumps, 2013: Summary recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"62","author":"McLean","year":"2013","journal-title":"Morb. Mortal. Wkly. Rep. Recomm. Rep."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.vaccine.2017.12.075","article-title":"Measles, mumps, and rubella antibody patterns of persistence and rate of decline following the second dose of the MMR vaccine","volume":"36","author":"Seagle","year":"2018","journal-title":"Vaccine"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/j.vaccine.2018.01.002","article-title":"Waning of measles maternal antibody in infants in measles elimination settings\u2014A systematic literature review","volume":"36","author":"Guerra","year":"2018","journal-title":"Vaccine"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/nri.2016.90","article-title":"Sex differences in immune responses","volume":"16","author":"Klein","year":"2016","journal-title":"Nat. Rev. Immunol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2856","DOI":"10.1080\/21645515.2019.1619402","article-title":"Assessment of population immunity to measles in Ontario, Canada: A Canadian Immunization Research Network (CIRN) study","volume":"15","author":"Bolotin","year":"2019","journal-title":"Hum. Vaccin. Immunother."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Blaizot, S., Herzog, S.A., Abrams, S., Theeten, H., Litzroth, A., and Hens, N. (2019). Sample size calculation for estimating key epidemiological parameters using serological data and mathematical modelling. BMC Med. Res. Methodol., 19.","DOI":"10.1186\/s12874-019-0692-1"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1093\/ije\/23.5.1078","article-title":"Sex differences in the humoral antibody response to live measles vaccine in young adults","volume":"23","author":"Green","year":"1994","journal-title":"Int. J. Epidemiol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1111\/j.1432-2277.2009.00927.x","article-title":"The aging of the immune system","volume":"22","author":"Weiskopf","year":"2009","journal-title":"Transpl. Int."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"e01047","DOI":"10.1128\/mBio.01047-14","article-title":"Vaccine-induced measles virus-specific T cells do not prevent infection or disease but facilitate subsequent clearance of viral RNA","volume":"5","author":"Lin","year":"2014","journal-title":"mBio"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1097\/PHH.0000000000000962","article-title":"CDC Guidance for Use of a Third Dose of MMR Vaccine During Mumps Outbreaks","volume":"26","author":"Marlow","year":"2020","journal-title":"J. Public Health Manag. Pract."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Quach, H.Q., Chen, J., Monroe, J.M., Ratishvili, T., Warner, N.D., Grill, D.E., Haralambieva, I.H., Ovsyannikova, I.G., Poland, G.A., and Kennedy, R.B. (2022). The influence of sex, BMI, and age on cellular and humoral immune responses against measles after a 3rd dose of MMR vaccine. J. Infect. Dis., jiac351.","DOI":"10.1093\/infdis\/jiac351"}],"container-title":["Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-393X\/10\/11\/1859\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:09:55Z","timestamp":1760144995000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-393X\/10\/11\/1859"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,3]]},"references-count":25,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2022,11]]}},"alternative-id":["vaccines10111859"],"URL":"https:\/\/doi.org\/10.3390\/vaccines10111859","relation":{},"ISSN":["2076-393X"],"issn-type":[{"value":"2076-393X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,3]]}}}